Core contributor in ProRegio, ReCaM, ForZDM, and FORCE — all focused on manufacturing optimization, reconfigurable production, and zero-defect manufacturing.
ENGINSOFT SPA
Italian simulation SME applying computational engineering and modeling across manufacturing, biomedicine, HPC, and life sciences in EU research consortia.
Their core work
ENGINSOFT is an Italian SME specializing in computational engineering, simulation, and numerical modeling services. They provide advanced software-based engineering solutions — from finite element analysis and process simulation to high-performance computing optimization — across a wide range of industrial and scientific domains. Their core value lies in translating complex physical and biological phenomena into computational models that accelerate product development, manufacturing optimization, and scientific discovery. They act as the simulation and modeling partner in multidisciplinary consortia, applying their computational expertise to whatever domain the project demands.
What they specialise in
Participated in ExaNeSt (exascale interconnect/storage) and OPTIMA (optimizing industrial apps for heterogeneous HPC with FPGAs and accelerators).
Contributed to PREMUROSA (musculoskeletal regeneration, 3D bioprinting, in-silico models) and coordinated LIFESAVER (drug safety modeling, placenta pharmacology, bioprinting).
Participated in SYNCH — brain-silicon hybrid systems involving memristors, BCI, and neural network simulation.
Contributed to EDEN ISS, demonstrating plant cultivation technologies for space food production including vertical farming systems.
Participated in S4AllCities applying VR, digital twins, and AI/ML to urban safety and security challenges.
How they've shifted over time
In their early H2020 period (2015–2018), ENGINSOFT focused heavily on manufacturing simulation — reconfigurable production, product-service design, and zero-defect manufacturing — alongside contributions to space agriculture (EDEN ISS) and exascale computing (ExaNeSt). From 2019 onward, they pivoted significantly toward life sciences and biomedical modeling, taking on precision medicine (PREMUROSA), neural interface simulation (SYNCH), and ultimately coordinating LIFESAVER on drug safety and bioprinting. This shift from industrial manufacturing simulation toward biomedical computational modeling represents a deliberate expansion of their simulation expertise into higher-value, health-related domains.
ENGINSOFT is moving from traditional industrial simulation toward biomedical and life-science computational modeling, with their first coordinator role (LIFESAVER) signaling growing ambition and domain authority in health applications.
How they like to work
ENGINSOFT predominantly joins consortia as a specialist partner (9 out of 12 projects as participant), contributing computational and simulation expertise rather than leading project direction. With 164 unique partners across 26 countries, they operate as a flexible service provider that adapts to diverse consortium needs — a connector rather than a hub. Their recent step into coordination with LIFESAVER (their largest single grant at €800K) suggests growing confidence to lead, but their established pattern is as a trusted technical contributor that teams seek out for modeling capabilities.
Extensive European network spanning 164 unique partners across 26 countries, reflecting their role as a versatile simulation partner sought by diverse consortia. Their reach is genuinely pan-European, not concentrated in any single geographic cluster.
What sets them apart
ENGINSOFT's differentiator is their ability to apply computational engineering and simulation expertise across radically different domains — from zero-defect manufacturing to space agriculture to drug safety modeling. Most simulation SMEs specialize in one sector; ENGINSOFT has proven they can model physical, biological, and industrial systems with equal competence. For consortium builders, this means a single partner that can handle modeling work packages regardless of whether the project is about factory floors, brain-computer interfaces, or placental pharmacology.
Highlights from their portfolio
- LIFESAVERTheir only coordinator role and largest grant (€800K) — a bold move into drug safety and fetal health modeling that signals their strategic direction toward biomedical simulation.
- EDEN ISSUnusual cross-domain application: simulation expertise applied to space food production and controlled environment agriculture for Antarctic and space stations.
- SYNCHRepresents their frontier work in neuromorphic computing — modeling brain-silicon hybrid systems with memristors and neural networks, far from their manufacturing roots.